New UN Panel: All Eyes On Witty, Hamied?
This article was originally published in Scrip
Executive Summary
With expectations running high around the new heavyweight UN health panel, all eyes will probably be on whether or not the top executives of two of pharma's traditional rivals, GlaxoSmithKline and Cipla, can relent on delicate industry issues.